GSK plc Acquisitiondate Fair Value Of Total Consideration Transferred
GSK plc (GLAXF) had Acquisitiondate Fair Value Of Total Consideration Transferred of GBP 2.01 billion as of 2025-12-31, per its 20-F filed 2026-03-06.
Financial Statements › Notes
ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred · last filed 2026-03-06
- 2025-12-31: Acquisitiondate Fair Value Of Total Consideration Transferred 2.01B GBP.
- 2022-12-31: Acquisitiondate Fair Value Of Total Consideration Transferred 3.39B GBP.
| Period end | Acquisitiondate Fair Value Of Total Consideration Transferred |
|---|---|
| 2025-12-31 | 2.01B GBP 20-F · filed 2026-03-06 |
| 2022-12-31 | 3.39B GBP 20-F · filed 2025-03-03 |